Enhanced apoptosis of monocytes from complication-free juvenile-onset diabetes mellitus type 1 may be ameliorated by TNF- α inhibitors

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Myśliwska, Jolanta ^a   Ryba Stanisławowska, Monika ^a   Smardzewski, Marcin ^a   Słomiński, Bartosz ^a   Myśliwiec, Małgorzata ^a   Siebert, Janusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CD14 ANTIGEN; CD16 ANTIGEN; HUMAN IMMUNOGLOBULIN; INFLIXIMAB; LIPOCORTIN 5; TUMOR NECROSIS FACTOR RECEPTOR 1; FC RECEPTOR; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; APOPTOSIS; ARTICLE; CELL SURFACE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ANTIBODIES, MONOCLONAL; APOPTOSIS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MONOCYTES; RECEPTORS, IGG; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904682910     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/946209     Document Type: Article

References (51)

1. Leijon K., Hammarstrom B., Holmberg D., Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. International Immunology 1994 6 2 339 345 2-s2.0-0028031924 (Pubitemid 24055112)
2. + cytotoxic T-cell survival to enhance type 1 diabetes. Diabetes 2008 57 4 909 917 2-s2.0-42449104350 10.2337/db07-1256
3. Joussen A. M., Doehmen S., Le M. L., Koizumi K., Radetzky S., Krohne T. U., Poulaki V., Semkova I., Kociok N., TNF- α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Molecular Vision 2009 15 1418 1428 2-s2.0-68149131912
4. Jung D.-S., Lee S. H., Kwak S.-J., Li J. J., Kim D. H., Nam B.-Y., Kang H. Y., Chang T. I., Park J. T., Han S. H., Yoo T.-H., Kang S.-W., Apoptosis occurs differentially according to glomerular size in diabetic kidney disease. Nephrology Dialysis Transplantation 2012 27 1 259 266 2-s2.0-84863011417 10.1093/ndt/gfr301
5. Kühtreiber W. M., Hayashi T., Dale E. A., Faustman D. L., Central role of defective apoptosis in autoimmunity. Journal of Molecular Endocrinology 2003 31 3 373 399 2-s2.0-0346728631 10.1677/jme.0.0310373 (Pubitemid 38054512)
6. Ingaramo P. I., Ronco M. T., Francés D. E. A., Monti J. A., Pisani G. B., Ceballos M. P., Galleano M., Carrillo M. C., Carnovale C. E., Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus. Molecular Immunology 2011 48 12-13 1397 1407 2-s2.0-79957864582 10.1016/j.molimm.2011.03.015
7. Tennenberg S. D., Finkenauer R., Dwivedi A., Absence of lipopolysaccharide-induced inhibition of neutrophil apoptosis in patients with diabetes. Archives of Surgery 1999 134 11 1229 1234 2-s2.0-0032701495
8. Hanses F., Park S., Rich J., Lee J. C., Reduced neutrophil apoptosis in diabetic mice during staphylococcal infection leads to prolonged Tnf α production and reduced neutrophil clearance. PLoS ONE 2011 6 8 2-s2.0-80052283310 10.1371/journal.pone.0023633 e23633
9. Yan G., Fu Y., Faustman D. L., Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter. Journal of Immunology 1997 159 6 3068 3080 2-s2.0-0031571790 (Pubitemid 127681331)
10. Faustman D., Davis M., TNF receptor 2 pathway: drug target for autoimmune diseases. Nature Reviews Drug Discovery 2010 9 6 482 493 2-s2.0-77953136143 10.1038/nrd3030
11. 4 a new I kappa B alpha modifier, is associated with type 1 diabetes. Nature Genetics 2004 36 8 837 841 (Pubitemid 39014100)
12. 4 expression and NF B transcriptional activity. Biochemical and Biophysical Research Communications 2009 381 4 477 481 2-s2.0-62949206599 10.1016/j.bbrc.2009.02.060
13. 4 M55V (A163G) polymorphism and susceptibility to type 1 diabetes: a meta-analysis. Human Immunology 2012 73 10 1055 1059 2-s2.0-84866399868 10.1016/j.humimm.2012.07.341
14. Limb G. A., Chignell A. H., Green W., LeRoy F., Dumonde D. C., Distribution of TNF α and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. British Journal of Ophthalmology 1996 80 2 168 173 2-s2.0-0030065211 (Pubitemid 26058553)
15. Hatanaka E., Monteagudo P. T., Marrocos M. S. M., Campa A., Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clinical and Experimental Immunology 2006 146 3 443 447 2-s2.0-33750846406 10.1111/j.1365-2249.2006.03229.x (Pubitemid 44722162)
16. + monocytes from chronic kidney disease patients exhibit increased adhesion ability to endothelial cells. Contributions to Nephrology 2011 171 57 61 2-s2.0-79958093919 10.1159/000327134
17. Moriwaki Y., Inokuchi T., Yamamoto A., Ka T., Tsutsumi Z., Takahashi S., Yamamoto T., Effect of TNF- α inhibition on urinary albumin excretion in experimental diabetic rats. Acta Diabetologica 2007 44 4 215 218 2-s2.0-36248953302 10.1007/s00592-007-0007-6 (Pubitemid 350132266)
18. 5 in the circulation. American Journal of Pathology 2012 181 2 719 727 2-s2.0-84864124140 10.1016/j.ajpath. 2012.04.009
19. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D. N., Leenen P. J. M., Liu Y.-J., MacPherson G., Randolph G. J., Scherberich J., Schmitz J., Shortman K., Sozzani S., Strobl H., Zembala M., Austyn J. M., Lutz M. B., Nomenclature of monocytes and dendritic cells in blood. Blood 2010 116 16 e74 e80 2-s2.0-77958185103 10.1182/blood-2010-02-258558
20. + monocytes as a third monocyte subset. Blood 2011 118 12 e50 e61 2-s2.0-80053181958 10.1182/blood-2011-01-326827
21. Wong K. L., Yeap W. H., Tai J. J. Y., Ong S. M., Dang T. M., Wong S. C., The three human monocyte subsets: implications for health and disease. Immunologic Research 2012 53 1-3 41 57 2-s2.0-84866734182 10.1007/s12026-012- 8297-3
22. + monocytes producing TNF- α in complication-free diabetes type 1 juvenile onset patients. Cytokine 2012 60 1 309 317 2-s2.0-84865415513 10.1016/j.cyto.2012.03.010
23. Skinner N. A., MacIsaac C. M., Hamilton J. A., Visvanathan K., Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14 dimCD16+ monocytes in response to sepsis-related antigens. Clinical and Experimental Immunology 2005 141 2 270 278 2-s2.0-22344437528 10.1111/j.1365-2249.2005.02839.x (Pubitemid 41003351)
24. + T cells. International Immunology 2001 13 12 1571 1581 2-s2.0-0035207272 (Pubitemid 33133884)
25. + monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. Journal of Leukocyte Biology 2006 80 5 1156 1164 2-s2.0-33750458369 10.1189/jlb.0206125 (Pubitemid 44646321)
26. ++ monocytes are a major source of TNF. Journal of Immunology 2002 168 7 3536 3542 2-s2.0-0036533648 (Pubitemid 34250422)
27. Mobley J. L., Leininger M., Madore S., Baginski T. J., Renkiewicz R., Genetic evidence of a functional monocyte dichotomy. Inflammation 2007 30 6 189 197 2-s2.0-37249082600 10.1007/s10753-007-9036-0 (Pubitemid 350264453)
28. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2008 27 supplement 1 S55 S60
29. Chen P.-L., Easton A., Apoptotic phenotype alters the capacity of tumor necrosis factor-related apoptosis-inducing ligand to induce human vascular endothelial activation. Journal of Vascular Research 2008 45 2 111 122 2-s2.0-38549149463 10.1159/000109880 (Pubitemid 351651296)
30. Renshaw S. A., Parmar J. S., Singleton V., Rowe S. J., Dockrell D. H., Dower S. K., Bingle C. D., Chilvers E. R., Whyte M. K. B., Acceleration of human neutrophil apoptosis by TRAIL. Journal of Immunology 2003 170 2 1027 1033 2-s2.0-0037438471 (Pubitemid 36070558)
31. Mikołajczyk T. P., Skrzeczyńska-Moncznik J. E., Zarȩbski M. A., Marewicz E. A., Wiśniewska A. M., Dzieba M., Dobrucki J. W., Pryjma J. R., Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells. Immunology 2009 128 1 103 113
32. Secchiero P., Gonelli A., Carnevale E., Corallini F., Rizzardi C., Zacchigna S., Melato M., Zauli G., Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand. Neoplasia 2004 6 4 364 373 2-s2.0-3142733468 10.1593/neo.03421 (Pubitemid 38924851)
33. Thommesen L., Lægreid A., Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NF B. Journal of Biochemistry and Molecular Biology 2005 38 3 281 289 2-s2.0-25444447681 (Pubitemid 43034367)
34. Amann R., Peskar B. A., Anti-inflammatory effects of aspirin and sodium salicylate. European Journal of Pharmacology 2002 447 1 1 9 2-s2.0-0037188750 10.1016/S0014-2999(02)01828-9 (Pubitemid 34775215)
35. Cazanave S., Vadrot N., Tinel M., Berson A., Lettéron P., Larosche I., Descatoire V., Feldmann G., Robin M.-A., Pessayre D., Ibuprofen administration attenuates serum TNF- α levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation. Toxicology and Applied Pharmacology 2008 231 3 336 343 2-s2.0-51049093792 10.1016/j.taap.2008.05.010
36. Ibeas E., Fuentes L., Martín R., Hernández M., Nieto M. L., Inflammatory protein sPLA2-IIA abrogates TNF α -induced apoptosis in human astroglioma cells: crucial role of ERK. Biochimica et Biophysica Acta 2009 1793 12 1837 1847 2-s2.0-71749118336 10.1016/j.bbamcr.2009.10.004
37. Dreschers S., Gille C., Haas M., Grosse-Ophoff J., Schneider M., Leiber A., Bühring H.-J., Orlikowsky T. W., Infection-induced Bystander-Apoptosis of Monocytes is TNF-alpha-mediated. PLoS ONE 2013 8 1, article e53589 2-s2.0-84872569739 10.1371/journal.pone.0053589
38. Joussen A. M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Döhmen S., Adamis A. P., Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. The FASEB Journal 2002 16 3 438 440 2-s2.0-0036517850
39. Mastrandrea L., Yu J., Behrens T., Buchlis J., Albini C., Fourtner S., Quattrin T., Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care 2009 32 7 1244 1249 2-s2.0-67650079482 10.2337/dc09-0054
40. Migliore A., Massafra U., Carloni E., Padalino C., Martin Martin S., Lasaracina F., Dibiase N., Alimonti A., Granata M., TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report. European Review for Medical and Pharmacological Sciences 2005 9 6 373 378 2-s2.0-31844455558 (Pubitemid 43180328)
41. Sfikakis P. P., Markomichelakis N., Theodossiadis G. P., Grigoropoulos V., Katsilambros N., Theodossiadis P. G., Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab. Diabetes Care 2005 28 2 445 447 2-s2.0-12844263375 10.2337/diacare.28.2.445 (Pubitemid 40170961)
42. Moriwaki Y., Inokuchi T., Yamamoto A., Ka T., Tsutsumi Z., Takahashi S., Yamamoto T., Effect of TNF- α inhibition on urinary albumin excretion in experimental diabetic rats. Acta Diabetologica 2007 44 4 215 218 2-s2.0-36248953302 10.1007/s00592-007-0007-6 (Pubitemid 350132266)
43. Yamakawa I., Kojima H., Terashima T., Katagi M., Oi J., Urabe H., Sanada M., Kawai H., Chan L., Yasuda H., Maegawa H., Kimura H., Inactivation of TNF- α ameliorates diabetic neuropathy in mice. American Journal of Physiology-Endocrinology and Metabolism 2011 301 5 E844 E852 2-s2.0-80055016542 10.1152/ajpendo.00029.2011
44. Ebert E. C., Infliximab and the TNF- α system. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009 296 3 G612 G620 2-s2.0-65349138972 10.1152/ajpgi.90576.2008
45. Zizzo G., Hilliard B. A., Monestier M., Cohen P. L., Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. Journal of Immunology 2012 189 7 3508 3520 2-s2.0-84866554651 10.4049/jimmunol.1200662
46. Rutella S., Fiorino G., Vetrano S., Correale C., Spinelli A., Pagano N., Arena V., Maggiano N., Repici A., Malesci A., Danese S., Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with crohn's disease. American Journal of Gastroenterology 2011 106 4 762 770 2-s2.0-79953797881 10.1038/ajg.2011.48
47. Izquierdo E., Cañete J. D., Celis R., Santiago B., Usategui A., Sanmartí R., Rey M. J., Pablos J. L., Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS ONE 2009 4 12 2-s2.0-77953967440 10.1371/journal.pone.0008131 e8131
48. Min D., Brooks B., Wong J., Salomon R., Bao W., Harrisberg B., Twigg S. M., Yue D. K., McLennan S. V., Alterations in Monocyte CD16 in association with diabetes complications. Mediators of Inflammation 2012 2012 10 2-s2.0-84872165940 10.1155/2012/649083 649083
49. 5 in the circulation. American Journal of Pathology 2012 181 2 719 727 2-s2.0-84864124140 10.1016/j.ajpath. 2012.04.009
50. Chen Y., Hu Y., Lin M., Jenkins A. J., Keech A. C., Mott R., Lyons T. J., Ma J.-X., Therapeutic effects of PPAR α agonists on diabetic retinopathy in type 1 diabetes models. Diabetes 2013 62 1 261 272 2-s2.0-84872016068 10.2337/db11-0413
51. Rangasamy S., McGuire P. G., Das A., Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East African Journal of Ophthalmology 2012 19 1 52 59 2-s2.0-84856397889 10.4103/0974-9233.92116